Stride (NYSE: LRN) director reports 4,097-share restricted stock grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Stride, Inc. director reported receiving a grant of restricted common stock. On 12/04/2025, an indirect account, the S&C Fink Living Trust, acquired 4,097 shares of Stride common stock at a stated price of $0, reflecting an equity award rather than an open‑market purchase. After this grant, the trust holds 175,607 shares of Stride common stock indirectly. These restricted shares will vest on the earlier of December 4, 2026, or the next annual meeting of Stride stockholders.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
FINK STEVEN B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,097 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 175,607 shares (Indirect, S&C Fink Living Trust)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Stride (LRN) disclose in this Form 4?
A Stride, Inc. director reported an indirect acquisition of 4,097 restricted shares of Stride common stock through the S&C Fink Living Trust on 12/04/2025.
What is the relationship of the reporting person to Stride (LRN)?
The reporting person is a director of Stride, Inc., and filed the transaction as an indirect ownership position through the S&C Fink Living Trust.
Is this Form 4 filing for Stride (LRN) a joint or individual filing?
This is an individual filing, indicated as Form filed by One Reporting Person.